Unwellness testing is blood testing for people whose standard labs come back normal but who still feel unwell: the people medicine has no answers for yet. It measures highly selected immune and inflammatory proteins that routine panels do not, so persistent symptoms can be tracked and made visible against a healthy reference. Mune is the unwellness company. We coined the term unwellness testing and built Mune Mirror™* around it. Mune Mirror™ is investigational and for research and informational use. It does not diagnose, treat, cure or prevent any disease.
Key facts
- Definition
- Blood testing for people whose standard labs read normal but who still feel unwell.
- Coined by
- Mune, the unwellness company.
- Measures
- Immune and inflammatory proteins that routine panels leave out, each benchmarked against a healthy reference.
- Method
- A baseline measurement, then retests, so change sits against objective data.
- Read by
- You and your own doctor.
- It is not
- A diagnosis, a longevity panel or a test for one condition.
- Mune Mirror™ status
- In development. The performance characteristics of this test have not yet been established.
- Research
- The Mune Mirror™ Baseline Study starts on 15 October 2026.
Key takeaways
- Unwellness testing is for people whose symptoms persist while their standard blood work comes back normal.
- Routine panels look for common conditions such as anemia or thyroid disease. The CDC notes that routine blood tests may be normal in someone with long COVID.
- An unwellness test measures a broad set of immune and inflammatory proteins, benchmarks each one against a healthy reference and repeats the measurement over time.
- The results name no condition and point to no treatment. You bring them to your own doctor.
- Mune Mirror™ is investigational. The Mune Mirror™ Baseline Study measures people living with long COVID beside healthy participants from 15 October 2026.
Who is unwellness testing for?
Unwellness testing is for adults who have felt unwell for weeks or months, whose symptoms get in the way of daily life, and whose standard blood tests have come back inside the normal range. The symptoms differ from person to person: fatigue that sleep does not touch, a general sense of malaise, brain fog, pain, a racing heart on standing, or a crash after effort you used to manage without a second thought.
Many people in this position have heard that nothing is wrong. The situation is common: about one in five primary care consultations involve persistent symptoms that doctors cannot explain with standard diagnostic criteria. A normal routine panel means the panel found none of the common causes it looks for. It says little about the immune signalling outside its menu.
For long COVID, the CDC states that no approved laboratory test can determine whether symptoms are due to the condition, and that routine blood tests, chest X-rays and ECGs may be normal. Long COVID comes first in Mune's research. ME/CFS and POTS follow, then autoimmune and brain-body conditions, mental health among them.
What does unwellness testing measure?
An unwellness test reads the proteins that carry immune and inflammatory signals through the blood: cytokines such as IL-6 and TNF-α, interferons such as IFN-γ, chemokines such as IP-10, and markers of mast cell, blood vessel and nervous system activity such as tryptase, VEGF-A and NfL. Mune Mirror™ measures more than 1,000 of these proteins from one at-home sample. The list of what Mune Mirror™ measures shows the eight domains and example markers in each.
Three design choices separate it from a routine panel:
- Breadth. A large study found common lab tests unreliable for diagnosing long COVID (CU Anschutz), while researchers who profiled the immune system across many measures could separate long COVID from recovery at the group level (Klein et al., Nature 2023). In that research the differences appeared as patterns across many measures, and the inflammation markers on a standard panel cover few of them.
- A healthy reference. Mune places each protein against levels measured in healthy people, so you and your doctor can see where each value sits, marker by marker.
- Repetition. The FDA-NIH BEST glossary calls a marker measured at intervals to assess change a monitoring biomarker. One draw gives a snapshot of one day. A series shows direction.
Laboratory methods make this breadth possible. Affinity-based proteomics platforms quantify thousands of protein targets in blood (Nature Communications, 2021), and single-molecule immunoassays have measured cytokines such as IL-6 and TNF-α at concentrations as low as 0.01 to 0.03 pg/mL (2023 assay study).
What is unwellness testing not?
- A diagnosis. The CDC states that no approved laboratory test can determine whether symptoms are due to long COVID. A 2023 systematic review found no validated diagnostic biomarker for ME/CFS. An unwellness test measures proteins and compares them with a healthy reference; your doctor makes any diagnosis, from your history, an examination and the tests they choose.
- A longevity panel. Longevity and wellness panels read broad menus of routine clinical markers (chemistry, hormones, nutrients and more) by body system, for general health screening. Unwellness testing starts from a different question: what the immune system is doing in someone who feels unwell.
- A test for one condition. A tilt table test records heart rate and blood pressure for POTS, and serum tryptase supports a mast cell activation workup. An unwellness test reads many pathways at the same time and names no condition.
- A replacement for standard care. Standard blood work comes first. The CDC's guidance for clinicians evaluating ME/CFS lists basic screening tests, from a complete blood count to thyroid tests and CRP, to look for other conditions. Those results matter, and a normal one is useful information.
How does unwellness testing differ from standard blood work, longevity panels and single-condition tests?
The four approaches answer different questions, and a person with persistent symptoms may meet all of them. The table sets them side by side.
| Approach | What it measures | The question it answers | How it relates to unwellness testing |
|---|---|---|---|
| Standard blood work | A complete blood count, a metabolic panel, thyroid tests, ESR and CRP, urinalysis (CDC) | Is a common, treatable condition such as anemia or thyroid disease behind the symptoms? | Comes first. Unwellness testing starts where these results come back normal. |
| Longevity and wellness panels (for example Function Health, Superpower) | Function Health lists 160+ lab tests a year across hormones, heart, thyroid, nutrients, metals, metabolic health, autoimmunity, liver and electrolytes (functionhealth.com). Superpower lists 100+ biomarkers across heart health, hormones, metabolic health, inflammation, nutrients, liver and kidney (superpower.com). Both checked on 23 September 2026. | Broad health screening across body systems. | A different focus. Their published menus list routine clinical markers by body system; an unwellness panel reads 1,000+ immune and inflammatory proteins. |
| Single-condition tests | One marker or one physiological test: a tilt table test for POTS (HRS criteria), serum tryptase for mast cell activation (consensus criteria), Epstein-Barr virus antibodies (CDC) | Does this one condition fit? | Narrow by design. Unwellness testing reads many immune pathways at the same time and confirms no single condition. |
| Unwellness testing (Mune Mirror™) | 1,000+ immune and inflammatory proteins, each benchmarked against a healthy reference | Do my immune and inflammatory proteins sit inside healthy levels, and do they change over time? | For research and informational use, read with your own doctor. |
How does the Mune Mirror™ Baseline Study fit?
The Mune Mirror™ Baseline Study measures the panel in two groups: 50 people living with long COVID and 300 healthy participants. It starts on 15 October 2026. Each participant gives up to three at-home blood draws and receives their own results.
Healthy, for the study, means no current symptoms, no chronic condition, no regular medication, no past long COVID or other post-viral illness, and an age of 18 or over. Sign-up is an application, and applying does not guarantee a place.
For someone living with long COVID who wants objective data, the study is the next step: if Mune offers you a place, you take part in research that measures people with long COVID beside healthy participants, and you see your own measurements. Read about the Baseline Study and apply.
Where Mune Mirror™ fits
Mune Mirror™ is Mune Biotech's unwellness test: an at-home blood test that measures 1,000+ proteins with an immune and inflammation focus and benchmarks each one against a healthy reference, and that you repeat over time. You keep a measured record beside your symptom history and bring it to your own doctor.
It names no condition and recommends no treatment. Its job is measurement: where your immune and inflammatory proteins sit, and how they move.
Unwellness testing is blood testing for people whose standard labs come back normal but who still feel unwell: the people medicine has no answers for yet. It measures highly selected immune and inflammatory proteins that routine panels do not, so persistent symptoms can be tracked and made visible against a healthy reference. Mune is the unwellness company. We coined the term unwellness testing and built Mune Mirror™ around it. Mune Mirror™ is investigational and for research and informational use. It does not diagnose, treat, cure or prevent any disease.
Frequently asked questions
Is unwellness testing a diagnosis?
No. Unwellness testing measures immune and inflammatory proteins and compares them with a healthy reference. It does not diagnose, treat, cure or prevent any disease. A doctor makes a diagnosis from your history, an examination and the tests they choose, and the results are data you can bring to that conversation.
Is there a test for long COVID?
The CDC states that there is no approved laboratory test that can determine whether symptoms are due to long COVID, and routine blood tests may be normal. Research panels measure immune proteins that differ between groups with and without long COVID. The Mune Mirror™ Baseline Study measures people with long COVID beside healthy participants from 15 October 2026.
How is unwellness testing different from a longevity panel?
Longevity and wellness panels read broad menus of routine clinical markers, such as chemistry, hormones and nutrients, across body systems for general health screening. Unwellness testing reads immune and inflammatory proteins in people who feel unwell and whose standard labs are normal, and it repeats the measurement to track change.
Can unwellness testing replace my standard blood work?
No. Standard tests look for common and treatable causes of symptoms, such as anemia or thyroid disease, and they come first. Unwellness testing adds a different layer of measurement once those results are back. Share both with your doctor.
Why retest instead of testing once?
One draw shows where each protein sits on one day. Symptoms and immune signals change across weeks and months. Researchers call a marker measured at intervals to assess change a monitoring biomarker, and a series of results shows a direction that a single result cannot.
What if my symptoms are new or getting worse?
New, severe or worsening symptoms need a medical assessment first, and urgent symptoms need urgent care. Unwellness testing is for persistent symptoms that a standard workup has not explained. It is no way to rule out a serious condition.
Topic guides
- Malaise: feeling unwell with normal labsMalaise has a medical name, it appears in clinical criteria, and researchers can measure some of the biology that travels with it.
- Long COVID: symptoms, testing and researchLong COVID is an infection-associated chronic condition with no approved laboratory test. Research panels measure the immune differences studies have found, and clinical trials are testing treatments for its symptoms.
- POTS testing and inflammationClinicians diagnose POTS from how your heart rate and blood pressure respond to standing. Blood tests play a supporting part, and researchers are studying immune activity in POTS.
- Inflammation markers: the complete guideA standard blood test reads inflammation through one or two downstream numbers. The immune system signals through many more proteins, and a broader panel measures them.
- Brain fog: causes and what can be measuredPeople use the words brain fog for something real: slower thinking, lost words, trouble holding focus. Doctors look for treatable causes first, and research ties part of the picture to immune signalling.
- MCAS testing: what the workup measuresMast cell activation syndrome is hard to pin down because its markers rise and fall within hours. The consensus workup depends on catching a flare, and a draw on a quiet day can read normal.
- Always tired: fatigue and post-viral fatigueFatigue that sleep does not relieve is among the top 10 reasons people see a family doctor. Some of it has a clear, treatable cause, and some outlasts every normal result.
- ME/CFS testing and the immune systemME/CFS is a serious, long-term biological illness with no diagnostic blood test. Clinicians diagnose it from clinical criteria, and researchers are studying its immune biology.
- Fibromyalgia blood tests and inflammationDoctors diagnose fibromyalgia from symptoms, and the standard blood work reads normal. Research on cytokines and neuroinflammation is active, and it has produced no diagnostic test.
- Proteomics testing explainedA standard blood test reads a handful of proteins. A proteomics test reads hundreds or thousands from one sample, which widens the questions a blood draw can help with and leaves its limits in place.
Sources
- CDC. Long COVID Basics.
- Medically unexplained symptoms in primary care: how can doctors help, not hinder? 2011.
- University of Colorado Anschutz Medical Campus. Largest study of its kind finds common lab tests aren't reliable for diagnosing long COVID.
- Klein J, et al. Distinguishing features of long COVID identified through immune profiling. Nature, 2023.
- FDA-NIH Biomarker Working Group. BEST Resource: Monitoring Biomarker.
- Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nature Communications, 2021.
- A fully-automated, six-plex single molecule immunoassay for measuring cytokines in blood. 2023.
- Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. BMC Medicine, 2023.
- CDC. Evaluation of ME/CFS (for clinicians).
- Function Health. What Function Health tests (functionhealth.com, checked 23 September 2026).
- Superpower. Blood Test: 100+ Biomarkers (superpower.com, checked 23 September 2026).
- Sheldon RS, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm, 2015.
- Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review. Journal of Allergy and Clinical Immunology: In Practice, 2021.
- CDC. Laboratory Testing for Epstein-Barr Virus (EBV).
Last reviewed: September 23, 2026. By the Mune editorial team.
Mune Mirror™ is currently in development, and the performance characteristics of this test have not yet been established. It is investigational. It does not diagnose, detect, screen for, treat, cure or prevent any disease. Results are for research and informational purposes, to discuss with your own doctor.